Sign In

Jennifer Davagian

Chief Executive Officer at Cristcot

Jennifer Davagian is the founder and CEO of Cristcot, a drug development company based in Massachusetts. Cristcot's flagship product, Sephure, is an FDA-cleared drug delivery device with strong intellectual property, including 2 US Patents, aimed at revolutionizing the administration of suppository medication.

Before establishing Cristcot, Jennifer ran a successful consulting business serving the design trade industry. However, a significant health event inspired her to create Sephure, leveraging her management and manufacturing expertise along with insights from industry experts to propel the product from concept to the verge of scaled production and commercialization in 2013.

Under Jennifer's leadership, Cristcot is currently engaged in clinical studies for its first proprietary pharmaceutical drug. The company has received partial funding from the Massachusetts Life Science Center and was recognized as one of the top five promising emerging life science firms in the Commonwealth in 2012.

J
Add to my network

Location

Greater Boston Area